- Home
- POAI vs ATLCP Comparison
POAI vs ATLCP Comparison
Compare POAI & ATLCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- ATLCP
- Stock Information
- Founded
- POAI 2002
- ATLCP N/A
- Country
- POAI United States
- ATLCP United States
- Employees
- POAI 35
- ATLCP 417
- Industry
- POAI Industrial Specialties
- ATLCP Finance: Consumer Services
- Sector
- POAI Health Care
- ATLCP Finance
- Exchange
- POAI Nasdaq
- ATLCP Nasdaq
- Market Cap
- POAI 9.9M
- ATLCP N/A
- IPO Year
- POAI N/A
- ATLCP N/A
- Fundamental
- Price
- POAI $1.30
- ATLCP $22.50
- Analyst Decision
- POAI Hold
- ATLCP
- Analyst Count
- POAI 1
- ATLCP 0
- Target Price
- POAI N/A
- ATLCP N/A
- AVG Volume (30 Days)
- POAI 8.1M
- ATLCP N/A
- Earning Date
- POAI 05-13-2025
- ATLCP N/A
- Dividend Yield
- POAI N/A
- ATLCP N/A
- EPS Growth
- POAI N/A
- ATLCP N/A
- EPS
- POAI N/A
- ATLCP N/A
- Revenue
- POAI $1,623,817.00
- ATLCP N/A
- Revenue This Year
- POAI $486.27
- ATLCP N/A
- Revenue Next Year
- POAI $65.50
- ATLCP N/A
- P/E Ratio
- POAI N/A
- ATLCP N/A
- Revenue Growth
- POAI N/A
- ATLCP N/A
- 52 Week Low
- POAI $0.55
- ATLCP N/A
- 52 Week High
- POAI $3.06
- ATLCP N/A
- Technical
- Relative Strength Index (RSI)
- POAI 48.03
- ATLCP 36.28
- Support Level
- POAI $1.26
- ATLCP $23.01
- Resistance Level
- POAI $1.58
- ATLCP $23.33
- Average True Range (ATR)
- POAI 0.21
- ATLCP 0.14
- MACD
- POAI 0.01
- ATLCP -0.02
- Stochastic Oscillator
- POAI 16.13
- ATLCP 0.00
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About ATLCP Atlanticus Holdings Corporation 7.625% Series B Cumulative Perpetual Preferred Stock no par value per share
Atlanticus Holdings Corp invests in the financial services industry. It provides various credit and related financial services and products to or associated with the financially underserved consumer credit market. The operating business segments are the Credit as a Service (CaaS) and the Auto Finance segment. It generates maximum revenue from the Credit as a Service segment.